UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An imbalance in competing mortality favouring Debio 1143 – Authors' reply

The lancet oncology, 2020-11, Vol.21 (11), p.e503-e503

2020

Volltextzugriff (PDF)

Letter to the Editor: SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responses

Cellular immunology, 2024-01, Vol.395-396, p.104772-104772, Article 104772

2024

Volltextzugriff (PDF)

10-Year Locoregional Control with Postoperative External Beam Radiotherapy in Patients with Locally Advanced High-Risk Non-Anaplastic Thyroid Carcinoma De Novo or at Relapse, a Propensity Score Analysis

Cancers, 2019-06, Vol.11 (6), p.849

2019

Volltextzugriff (PDF)

Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial

Radiotherapy and oncology, 2024-08, Vol.197, p.110329, Article 110329

2024

Volltextzugriff (PDF)

Long-term results from a clinical study of xevinapant plus chemoradiotherapy in people with high-risk locally advanced squamous cell carcinoma of the head and neck: a plain language summary

Future oncology (London, England), 2023-08, Vol.19 (26), p.1769-1776

2023

Volltextzugriff (PDF)

A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network)

Critical reviews in oncology/hematology, 2014-08, Vol.91 (2), p.142-158

2014

Volltextzugriff (PDF)

Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC

Future oncology (London, England), 2018-04, Vol.14 (9), p.877-889

2018

Volltextzugriff (PDF)

Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus

Radiotherapy and oncology, 2021-07, Vol.160, p.140-147

2021

Volltextzugriff (PDF)

Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized trial GORTEC 2017-01 (REACH)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6076-6076

2018

Volltextzugriff (PDF)

Phase I/II and Pharmacokinetic Study of Intravenous Vinflunine in Combination With Cisplatin for the Treatment of Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer

Clinical lung cancer, 2010-03, Vol.11 (2), p.105-113

2010

Volltextzugriff (PDF)

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

European journal of cancer (1990), 2020-12, Vol.141, p.62-81

2020

Volltextzugriff (PDF)

The rare cancer network: ongoing studies and future strategy

Rare tumors, 2014-08, Vol.6 (3), p.5465-94

2014

Volltextzugriff (PDF)

1739: Local control patterns of GORTEC 2014-04 IIR Trial of SABR or chemo-SABR in oligometastastic HNSCCs

Radiotherapy and oncology, 2024-05, Vol.194, p.S1332-S1334

2024

Volltextzugriff (PDF)

Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial

Journal of clinical oncology, 2018-11, Vol.36 (31), p.JCO2017762518-3090

2018

Volltextzugriff (PDF)

Traitement des lymphomes thyroïdiens primitifs de stade localisé

Bulletin du cancer, 2013-10, Vol.100 (10), p.1031-1042

2013

Volltextzugriff (PDF)

Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients

International journal of radiation oncology, biology, physics, 2017-11, Vol.99 (3), p.590-595

2017

Volltextzugriff (PDF)

Dose escalation of radiotherapy (RT) for locally advanced head and neck carcinomas treated with concomitant chemotherapy (CT) and RT: Results of the GORTEC 2004-01 randomized trial

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6015-6015

2017

Volltextzugriff (PDF)

ELAN-ONCOVAL (Elderly Head and Neck Cancer-Oncology Evaluation) study: Evaluation of the G8 screening tool and the ELAN geriatric evaluation (EGE) for elderly patients (pts) with head and neck squamous cell carcinomas (HNSCC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.11541-11541

2019

Volltextzugriff (PDF)

1 – 25 von 4.079

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.501)
Mit Volltextzugriff
(3.574)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.316)
Life Sciences & Biomedicine
(1.321)
Physical Sciences
(701)
Humans
(667)
Technology
(535)
Physics
(477)
Male
(372)
Animals
(360)
Female
(349)
Chemistry
(342)
Materials Science
(278)
Science & Technology - Other Topics
(229)
Materials Science, Multidisciplinary
(226)
Middle Aged
(215)
Engineering
(209)
Adult
(188)
Mice
(176)
Astronomy & Astrophysics
(175)
Oncology
(175)
Aged
(164)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study

An imbalance in competing mortality favouring Debio 1143 – Authors' reply

Letter to the Editor: SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responses

Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary

10-Year Locoregional Control with Postoperative External Beam Radiotherapy in Patients with Locally Advanced High-Risk Non-Anaplastic Thyroid Carcinoma De Novo or at Relapse, a Propensity Score Analysis

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial

Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial

Long-term results from a clinical study of xevinapant plus chemoradiotherapy in people with high-risk locally advanced squamous cell carcinoma of the head and neck: a plain language summary

Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial

A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network)

Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC

Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus

Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized trial GORTEC 2017-01 (REACH)

Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Administration Propeukin Program Cooperative Group

Phase I/II and Pharmacokinetic Study of Intravenous Vinflunine in Combination With Cisplatin for the Treatment of Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial

The rare cancer network: ongoing studies and future strategy

1739: Local control patterns of GORTEC 2014-04 IIR Trial of SABR or chemo-SABR in oligometastastic HNSCCs

Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial

Traitement des lymphomes thyroïdiens primitifs de stade localisé

Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients

Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study

Dose escalation of radiotherapy (RT) for locally advanced head and neck carcinomas treated with concomitant chemotherapy (CT) and RT: Results of the GORTEC 2004-01 randomized trial

ELAN-ONCOVAL (Elderly Head and Neck Cancer-Oncology Evaluation) study: Evaluation of the G8 screening tool and the ELAN geriatric evaluation (EGE) for elderly patients (pts) with head and neck squamous cell carcinomas (HNSCC)

Suchergebnisse filtern